Scott D. Ballin | 27 October 2015
With an estimated one billion smokers in the world and with over 5 million people dying each year from the deadly cigarette, isn’t it time for all stakeholders to reevaluate the strategies that are being used? Isn’t time to take advantage of and incorporate harm reduction as an appropriate global strategy for reducing disease and death caused by cigarette smoking?
Christopher Russell | 4 October 2015
The finding of a recent survey commissioned by the UK charity Action on Smoking and Health (ASH)  that the proportion of 11-18 year olds in the UK who have tried using an electronic cigarette at least once rose from 5% in 2013 to 13% in 2015 will almost certainly lead to calls for greater restrictions to be placed on the ability of manufacturers and vendors to advertise nicotine vapour products. Perhaps there will even be calls, in time, for nicotine vapour products to be sold only in plain packaging as now occurs with all tobacco products in Australia. But are greater restrictions on the advertising of electronic cigarettes consistent with the priority public health goal of reducing tobacco-related disease?
Neil McKeganey | 9 September 2015
Tobacco control researchers are nothing if not inconsistent. Take, for example, the recent case of Professor David Nutt who convened a group of experts to assess the relative harm of different nicotine delivery products (Nutt et al 2015). The paper Nutt and colleagues published on the basis of their assessment formed part of Public Health England’s recent conclusion that electronic cigarettes were 95% less harmful than combustible tobacco.
Ian Dunt | 26 August 2015
If Public Health England's report on vaping shows anything, it's that those who oppose it are a threat to public health. The report found that "e-cigarette use is around 95% less harmful to health than smoking". They pose "no risk of nicotine poisoning to user". Most of the chemicals causing smoking-related disease are absent and "the chemicals present pose limited danger".
Marewa Glover | 17 July 2015
Trying to get people to stop smoking has been a public health priority in New Zealand for 30 years. We’ve harangued, shamed, stigmatised, pleaded with and incentivised smokers to quit. We’ve used taxes, banned smoking in most public indoor places, canned advertising and printed enough smokefree branded clothing to dress everyone on Tuvalu.
Neil McKeganey | 22 June 2015
The recent announcement from health officials in Wales that the use of e-cigarettes in public spaces will be banned has been received with a mix of enthusiasm from some, puzzlement from others, and downright dismay by many -including within the "vaping" community itself.
Hon Lik | Warsaw, 14:30, Friday 5th June 2015
Good afternoon, ladies and gentlemen. I’m delighted to welcome you here today at The Global Forum on Nicotine, an event that has become one of the highlights of the year for the people and organisations who are shaping the present and future of nicotine products.
It’s wonderful, and still astonishing, to see so many faces at this event – especially when I think back to how the industry used to be. I may be revealing my age here, but when I first started working with nicotine products, I was a lone voice struggling to be heard.
Scott D. Ballin | 3 June 2015
THE TOBACCO WARS*
Many in the e-vaping space may be wondering why they being viewed and treated like 'Big Tobacco' and why many in the tobacco control community find it so convenient to question their products and their motivations at every turn, painting them all with the same broad brush strokes. There are many reasons - some of which may be valid and many others which are not. What follows is a brief historical perspective of the ‘tobacco wars’ and provides some insights as to why many are still fighting those wars even though these are very different times.
Atakan Befrits | 16 March 2015
Cautionary words on the threat to vapers and vaping in Sweden, from Atakan Befrits
Vaping with nicotine in Sweden is now de jure banned following a recent court ruling.
Import, distribution and sales of nicotine containing e-cig and nicotine containing refills are banned by the Medical Products Agency (MPA) in Sweden, unless they are registered as medical products. This is prior to the implementation of the TPD, which provides for some flexibility on distribution and sales, which will continue for the time being, pending an appeal against the judgement.
S. Shiffman, M. Sembower, J. Pillitteri, K. Gerlach, J. Gitchell | 09 March 2015
Subsequent to publication of our paper, Stan Glantz published a critique of our study on the University of California, San Francisco Center for Tobacco Control Research and Education website. The critique was familiar – it was, in fact, the critique offered by one of the four anonymous expert referees who reviewed our paper for the journal Nicotine and Tobacco Research. In the end, the journal, in deciding to publish the paper, decided that we had overcome these concerns and that the paper was a valuable addition to the literature.